LIN, W., HSU, C., CHEN, Y., CHANG, M., LIANG, K., HUANG, Y., & YEH, C. (2014). GALNT14 genotype, α-fetoprotein and therapeutic side effects predict post-chemotherapy survival in patients with advanced hepatocellular carcinoma. D.A. Spandidos.

LIN, WEY-RAN, CHAO-WEI HSU, YI-CHENG CHEN, MING-LING CHANG, KUNG-HAO LIANG, YA-HUI HUANG, und CHAU-TING YEH. GALNT14 Genotype, α-fetoprotein and Therapeutic Side Effects Predict Post-chemotherapy Survival in Patients With Advanced Hepatocellular Carcinoma. D.A. Spandidos, 2014.

LIN, WEY-RAN, et al. GALNT14 Genotype, α-fetoprotein and Therapeutic Side Effects Predict Post-chemotherapy Survival in Patients With Advanced Hepatocellular Carcinoma. D.A. Spandidos, 2014.